Florence Chaverneff, Ph.D.

Intrathecal injection of pH-responsive nanoparticles containing the neurokinin 1 receptor antagonist, aprepitant, and targeting acidified endosomes of spinal neurons, was found to inhibit induced nociception in rodents.

Noninvasive vagus nerve stimulation may represent an effective acute intervention for episodic, but not chronic, cluster headache.

For the first time in the United States, titanium bone-anchored implants were used to repair large annular defects during diskectomies.

Tanezumab may effectively improve pain and physical function in patients with moderate to severe hip or knee osteoarthritis pain.

A smartphone application providing a progressive muscle relaxation intervention was adopted by approximately half of patients with migraine introduced to this option.

The US Food and Drug Administration is seeking feedback from healthcare professionals on its proposal to offer fixed-quantity blister packaging for a select number of opioid medications.

Virtual reality technology may be useful in such areas as exposure therapy and pain management.

The implementation of a standardized medication regimen for pain management in incoming psychiatric inpatients may be associated with a reduction in the number of pages related to pain complaints received by on-call residents.

The American Psychiatric Association’s president, Altha Stewart, MD, sat with Valerie Jarrett, JD, for a fireside chat focused on the Affordable Care Act.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may represent effective migraine prophylactic treatments.